Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hilte Geerdes-Fenge

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Infection|October 1, 2024
No substantial neurocognitive impact of COVID-19 across ages and disease severity: a multicenter biomarker study of SARS-CoV-2 positive and negative adult and pediatric patients with acute respiratory tract infectionsJohannes Ehler, Felix Klawitter, Friedrich von Möllendorff, et al.
Respiration; International Review of Thoracic Diseases|May 29, 2024
Treatment of MDR, Pre-XDR, XDR, and Rifampicin-Resistant Tuberculosis or in Case of Intolerance to at Least Rifampicin in Austria, Germany, and SwitzerlandRalf Otto-Knapp, Torsten Bauer, Folke Brinkmann, et al.
Pneumologie (Stuttgart, Germany)|November 17, 2022
[Tuberculosis in adulthood - The Sk2-Guideline of the German Central Committee against Tuberculosis (DZK) and the German Respiratory Society (DGP) for the diagnosis and treatment of adult tuberculosis patients]Tom Schaberg, Folke Brinkmann, Cornelia Feiterna-Sperling, et al.
Pneumologie (Stuttgart, Germany)|November 6, 2023
[Treatment of MDR, pre-XDR, XDR and rifampicin resistant tuberculosis or in case of intolerance to at least rifampicin in Austria, Germany and Switzerland - Amendment dated 19.09.2023 to the Sk2-Guideline: Tuberculosis in adulthood of the German Central Committee against Tuberculosis (DZK) on behalf of the German Respiratory Society (DGP)]Ralf Otto-Knapp, Torsten Bauer, Folke Brinkmann, et al.
Respiration; International Review of Thoracic Diseases|March 1, 2022
Risk Assessment for Patients with Chronic Respiratory Conditions in the Context of the SARS-CoV-2 Pandemic Statement of the German Respiratory Society with the Support of the German Association of Chest PhysiciansMarek Lommatzsch, Klaus F Rabe, Christian Taube, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 14, 2026
S3 Guideline for the treatment of psoriasis vulgaris, adapted from EuroGuiDerm - part 1: Treatment recommendations and monitoringAlexander Nast, Andreas Altenburg, Matthias Augustin, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|February 5, 2026
S3 Guideline for the Treatment of Psoriasis vulgaris, adapted from EuroGuiDerm - part 2: Specific clinical and comorbid situationsAlexander Nast, Andreas Altenburg, Matthias Augustin, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Infection|October 1, 2024
No substantial neurocognitive impact of COVID-19 across ages and disease severity: a multicenter biomarker study of SARS-CoV-2 positive and negative adult and pediatric patients with acute respiratory tract infectionsJohannes Ehler, Felix Klawitter, Friedrich von Möllendorff, et al.
Respiration; International Review of Thoracic Diseases|May 29, 2024
Treatment of MDR, Pre-XDR, XDR, and Rifampicin-Resistant Tuberculosis or in Case of Intolerance to at Least Rifampicin in Austria, Germany, and SwitzerlandRalf Otto-Knapp, Torsten Bauer, Folke Brinkmann, et al.
Pneumologie (Stuttgart, Germany)|November 17, 2022
[Tuberculosis in adulthood - The Sk2-Guideline of the German Central Committee against Tuberculosis (DZK) and the German Respiratory Society (DGP) for the diagnosis and treatment of adult tuberculosis patients]Tom Schaberg, Folke Brinkmann, Cornelia Feiterna-Sperling, et al.
Pneumologie (Stuttgart, Germany)|November 6, 2023
[Treatment of MDR, pre-XDR, XDR and rifampicin resistant tuberculosis or in case of intolerance to at least rifampicin in Austria, Germany and Switzerland - Amendment dated 19.09.2023 to the Sk2-Guideline: Tuberculosis in adulthood of the German Central Committee against Tuberculosis (DZK) on behalf of the German Respiratory Society (DGP)]Ralf Otto-Knapp, Torsten Bauer, Folke Brinkmann, et al.
Respiration; International Review of Thoracic Diseases|March 1, 2022
Risk Assessment for Patients with Chronic Respiratory Conditions in the Context of the SARS-CoV-2 Pandemic Statement of the German Respiratory Society with the Support of the German Association of Chest PhysiciansMarek Lommatzsch, Klaus F Rabe, Christian Taube, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 14, 2026
S3 Guideline for the treatment of psoriasis vulgaris, adapted from EuroGuiDerm - part 1: Treatment recommendations and monitoringAlexander Nast, Andreas Altenburg, Matthias Augustin, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|February 5, 2026
S3 Guideline for the Treatment of Psoriasis vulgaris, adapted from EuroGuiDerm - part 2: Specific clinical and comorbid situationsAlexander Nast, Andreas Altenburg, Matthias Augustin, et al.
Pageof 2